Advisors Management Group Inc Astrazeneca PLC Transaction History

Advisors Management Group Inc

$531 Million
Q2 2025

A detailed history of Advisors Management Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisors Management Group Inc holds 4,696 shares of AZN stock, worth $341,211. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,696

Previous 4,696 -0.0%

Holding current value

$341,211

Previous $345,000 4.93%

% of portfolio

0.06%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$64.85 - $71.7 $5,058 - $5,592	-78 Reduced 1.63%	4,696 $318,000
Q2 2023 Jul 19, 2023	SELL	$69.91 - $75.81 $9,787 - $10,613	-140 Reduced 2.85%	4,774 $342,000
Q1 2023 Apr 26, 2023	SELL	$63.15 - $71.6 $16,419 - $18,616	-260 Reduced 5.03%	4,914 $341,000
Q3 2022 Oct 21, 2022	SELL	$53.02 - $135.75 $901 - $2,307	-17 Reduced 0.33%	5,174 $284,000
Q3 2021 Oct 28, 2021	SELL	$55.56 - $60.79 $18,168 - $19,878	-327 Reduced 5.93%	5,191 $312,000
Q2 2021 Jul 21, 2021	SELL	$48.42 - $60.18 $6,246 - $7,763	-129 Reduced 2.28%	5,518 $331,000
Q1 2021 Apr 14, 2021	SELL	$47.16 - $54.44 $14,336 - $16,549	-304 Reduced 5.11%	5,647 $281,000
Q4 2020 Jan 14, 2021	SELL	$48.52 - $58.02 $9,704 - $11,604	-200 Reduced 3.25%	5,951 $297,000
Q3 2020 Nov 10, 2020	BUY	$53.07 - $61.1 $53 - $61	1 Added 0.02%	6,151 $337,000
Q2 2020 Aug 06, 2020	BUY	$43.1 - $55.31 $5,947 - $7,632	138 Added 2.3%	6,150 $325,000
Q1 2020 May 11, 2020	SELL	$37.79 - $51.33 $642 - $872	-17 Reduced 0.28%	6,012 $268,000
Q3 2019 Nov 15, 2019	SELL	$40.12 - $45.47 $14,282 - $16,187	-356 Reduced 5.58%	6,029 $269,000
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $7,306 - $8,169	-196 Reduced 2.98%	6,385 $264,000
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $70 - $86	2 Added 0.03%	6,581 $266,000
Q4 2018 Feb 15, 2019	SELL	$36.86 - $41.49 $24,032 - $27,051	-652 Reduced 9.02%	6,579 $250,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $69 - $79	2 Added 0.03%	7,231 $286,000
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $8,242 - $9,157	-250 Reduced 3.34%	7,229 $254,000
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $216,591 - $254,286	7,479	7,479 $253,000

Others Institutions Holding AZN

# of Institutions

1,430

Shares Held

507M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $225B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Advisors Management Group Inc with notifications on news.

Account

Advisors Management Group Inc Astrazeneca PLC Transaction History